Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zosano Pharma Corporation ZSANQ

Healthcare Biotechnology
Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K... see more

Recent & Breaking News (EXPM:ZSANQ)

Technical Reports on Biotech Stocks -- Bioverativ, Pulmatrix, PharmAthene, and Zosano Pharma

PR Newswire March 10, 2017

20 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  March 6, 2017

Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update

GlobeNewswire March 1, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  February 24, 2017

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  February 15, 2017

18 Biggest Mid-Day Gainers For Monday

Benzinga.com  February 13, 2017

Mid-Morning Market Update: Markets Open Higher; Teva Tops Q4 Estimates

Benzinga.com  February 13, 2017

Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine

GlobeNewswire February 13, 2017

Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire January 23, 2017

Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial

GlobeNewswire January 5, 2017

Zosano Pharma Announces Sale of Non-Strategic Asset

GlobeNewswire November 22, 2016

Zosano Pharma Reports Third Quarter 2016 Financial Results

GlobeNewswire November 9, 2016

Zosano Pharma Announces Completion of Enrollment in Pivotal Efficacy Trial for M207 for Acute Migraine

GlobeNewswire November 8, 2016

Zosano Announces Inducement Grant for Georgia Erbez, Chief Business Officer

GlobeNewswire September 9, 2016

Zosano Appoints Georgia Erbez as Chief Business Officer

GlobeNewswire September 8, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  August 30, 2016

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors With Losses in Excess of $10,000 Contact the Firm

Business Wire August 26, 2016

ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation

Business Wire August 26, 2016

Zosano Pharma Announces Pricing of Private Placement of Common Stock and Warrants

GlobeNewswire August 16, 2016

Zosano Pharma Reports Second Quarter 2016 Financial Results

GlobeNewswire August 10, 2016